The quantity of CD8 + T lymphocytes found in hematopoietic stem cell transplant recipients predicts the risk for HCMV infection in these recipients and has been linked with HCMV activation, associated disease protection, and immune recovery [37]. The gene discussed is CD8A; the disease is cytomegalovirus infection.